Related Experiment Video
Updated: May 21, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Stent thrombosis: an overview
Marinella Patrizia Centemero1, Jackson Rafael Stadler
1Instituto Dante Pazzanese of Cardiologia, 500 Dante Pazzanese Avenue, Sao Paulo, Brazil. mpcentemero@yahoo.com.br
Insights
Stent thrombosis remains a serious risk after percutaneous coronary intervention. Advanced stent designs and adherence to dual antiplatelet therapy are key to improving patient outcomes and reducing complications.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Stent thrombosis is a critical complication after percutaneous coronary intervention (PCI).
- The exact pathophysiology of stent thrombosis is not fully understood.
- Potential causes include incomplete stent healing and early cessation of dual antiplatelet therapy (DAPT).
Purpose of the Study:
- To review the challenges and potential solutions for reducing stent thrombosis.
- To highlight the role of novel stent designs and DAPT adherence.
Main Methods:
- Literature review of stent thrombosis pathophysiology and management.
- Analysis of factors contributing to stent thrombosis.
- Evaluation of emerging stent technologies.
Main Results:
- Incomplete stent endothelization, polymer presence, and poor stent apposition are implicated in thrombosis.
- Early discontinuation of DAPT is a significant predictor of stent thrombosis.
- New stent designs, including bioabsorbable materials and polymer-free options, show promise.
Conclusions:
- Improved stent technology and patient adherence to DAPT are crucial for minimizing stent thrombosis.
- Advanced stent designs can enhance safety and efficacy in complex PCI cases.
- Further research into stent materials and healing processes is warranted.
Abstract:
Stent thrombosis is a challenging problem following percutaneous coronary intervention that can lead to serious clinical consequences, such as death and acute myocardial infarction. Its pathophysiology is not yet completely known, and there are several causes suggested, such as incomplete stent endothelization, presence of polymers and late incomplete stent apposition. One of the main predictors is the early discontinuation of dual antiplatelet therapy. Stent improvements related to their design, with more friendly metallic platforms, thinner biocompatible or biodegradable polymers, absence of polymers, and even stents manufactured with bioabsorbable materials, could make the percutaneous procedure much safer and effective, allowing its application in increasingly complex anatomic and clinical scenarios, with low thrombosis rates.
Related Concept Videos
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
